Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) EBT Margin (2016 - 2025)

Veracyte's EBT Margin history spans 14 years, with the latest figure at 28.89% for Q4 2025.

  • For Q4 2025, EBT Margin rose 2603.0% year-over-year to 28.89%; the TTM value through Dec 2025 reached 13.19%, up 742.0%, while the annual FY2025 figure was 13.19%, 742.0% up from the prior year.
  • EBT Margin for Q4 2025 was 28.89% at Veracyte, up from 14.32% in the prior quarter.
  • Across five years, EBT Margin topped out at 28.89% in Q4 2025 and bottomed at 124.41% in Q1 2021.
  • The 5-year median for EBT Margin is 9.49% (2023), against an average of 12.23%.
  • The largest annual shift saw EBT Margin plummeted -8677bps in 2021 before it skyrocketed 10307bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 16.73% in 2021, then soared by 74bps to 4.29% in 2022, then plummeted by -624bps to 31.03% in 2023, then skyrocketed by 109bps to 2.87% in 2024, then skyrocketed by 908bps to 28.89% in 2025.
  • Per Business Quant, the three most recent readings for VCYT's EBT Margin are 28.89% (Q4 2025), 14.32% (Q3 2025), and 0.96% (Q2 2025).